Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...
News Medical on MSN1d
AI model identifies potential risk genes for Parkinson's diseaseResearchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
1don MSN
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive ...
At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.
ScienceAlert on MSN10d
Parkinson's Discovery Suggests We Could Already Have an FDA-Approved TreatmentResearchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
In the end, I have to be my best advocate for my own care. It took years, but when I became my best advocate, serious change happened,” Choi says.
A few years after Patrick Morrissey, 53, learned he had early onset Parkinson's disease, a group of friends came to him with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback